mail
versión imprimible
 
 

In Vivo Engineering of Therapeutic Cells Summit

Evvnt Promotion / evvnt
-
12.07.2022 - 14.07.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 08:00 - 17:30
 
Temas de la conferencia
Join the In Vivo Engineering of Therapeutic Cells Summit to Discover the Future of Cell and Gene Therapy!

In vivo gene engineering is fast becoming known as the future of cell and gene therapy with incredible amounts of investment seen in 2021, including the recent Moderna and Metagenomi collaboration alongside the partnership between Abintus Bio and MSKCC, and Tidal acquisition by Sanofi.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Adrian Bot, Chief Scientific Officer and Executive Vice President of R and D, Capstan Therapeutics, Andy Scharenberg, Chief Executive Officer, Umoja Biopharma, Cory Bentley, Co-Founder & Senior Vice President of R and D, Abintus Bio & more.
 

Información e inscripción:

https://go.evvnt.com/1038825-1?pid=4832
Mr. In Vivo Engineering of Therapeutic Cells Summit
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Drug Developers (Earlybird rates and workshops available): USD 2999.0, Academic (Earlybird rates and workshops available): USD 2599.0, Service Providers (Earlybird rates and workshops available): USD 3599.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Center of ExcellenceSwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.European Public Health Association (EUPHA)Österreichische Gesellschaft für Public HealthAlumni Club Medizinische Universität WienÄrztekammer für WienAMREF - African Medical and Research Foundation